Systemic sclerosis-associated pulmonary arterial hypertension and pulmonary fibrosis: exploring biomarker discriminators with advanced omics in a Caucasian cohort.
Saved in:
| Title: | Systemic sclerosis-associated pulmonary arterial hypertension and pulmonary fibrosis: exploring biomarker discriminators with advanced omics in a Caucasian cohort. |
|---|---|
| Authors: | Mohamed-Ali N; Centre of Metabolism and Inflammation, Department of Inflammation and Rare Diseases, Division of Medicine, University College London, London, United Kingdom., Acquaah V; Centre for Rheumatology, Department of Inflammation and Rare Diseases, Division of Medicine, University College London, London, United Kingdom., Al-Jaber M; Anti-Doping Lab Qatar, Doha, Qatar., Bhatt R; Centre of Metabolism and Inflammation, Department of Inflammation and Rare Diseases, Division of Medicine, University College London, London, United Kingdom., Al-Mohannadi I; Centre of Metabolism and Inflammation, Department of Inflammation and Rare Diseases, Division of Medicine, University College London, London, United Kingdom., Sastry KS; Anti-Doping Lab Qatar, Doha, Qatar., Beotra A; Anti-Doping Lab Qatar, Doha, Qatar., Knight D; Department of Cardiac MRI, Royal Free London NHS Foundation Trust, London, United Kingdom.; Institute of Cardiovascular Science, University College London, London, United Kingdom., Denton C; Centre for Rheumatology, Department of Inflammation and Rare Diseases, Division of Medicine, University College London, London, United Kingdom., Ong V; Centre for Rheumatology, Department of Inflammation and Rare Diseases, Division of Medicine, University College London, London, United Kingdom., Al-Nesf MA; Centre of Metabolism and Inflammation, Department of Inflammation and Rare Diseases, Division of Medicine, University College London, London, United Kingdom.; Allergy and Immunology Division, Department of Medicine, Hamad Medical Corporation, Doha, Qatar., Abraham D; Centre for Rheumatology, Department of Inflammation and Rare Diseases, Division of Medicine, University College London, London, United Kingdom., Al-Maadheed M; Centre of Metabolism and Inflammation, Department of Inflammation and Rare Diseases, Division of Medicine, University College London, London, United Kingdom.; Anti-Doping Lab Qatar, Doha, Qatar., Ponticos M; Centre for Rheumatology, Department of Inflammation and Rare Diseases, Division of Medicine, University College London, London, United Kingdom., Mohamed-Ali V; Centre of Metabolism and Inflammation, Department of Inflammation and Rare Diseases, Division of Medicine, University College London, London, United Kingdom.; Anti-Doping Lab Qatar, Doha, Qatar. |
| Source: | Frontiers in immunology [Front Immunol] 2026 Feb 02; Vol. 17, pp. 1755076. Date of Electronic Publication: 2026 Feb 02 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2026.1755076 |
